During a live event, Christine Bestvina, MD, discussed trials of KRAS inhibitors plus immunotherapy in patients with ...

In a new paper, a team from Yale and Fred Hutch has found autoantibody reactivity could predict cancer patients' response to ...

A landmark study has revealed that autoantibodies — immune proteins traditionally associated with autoimmune disease — may ...

Lurbinectedin plus atezolizumab significantly reduced the risk of disease progression or death by 46% compared with atezolizumab alone.

Researchers saw some cases where a patient’s own autoantibodies boosted likelihood of responding to checkpoint blockade.

A new study has revealed that autoantibodies—immune proteins traditionally associated with autoimmune disease—may profoundly ...

Radiation therapy, once thought of mainly as a local cancer treatment, is now showing power to awaken the immune system in surprising ways. Researchers discovered that combining radiation with ...

During a live event, Bruna Pellini, MD, discussed IO monotherapy as a first-line option for non–small cell lung cancer with ...

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...

By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...

A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...

By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...